Login / Signup

Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.

Armelle ForrerSamuel WanjiElisabeth Dibando ObieTheobald Mue NjiLouise HamillKim OzanoHelen PiotrowskiLaura DeanAbdel Jelil NjouendouRelindis EkanyaWinston Patrick Chounna NdongmoEbua Gallus FungDum-Buo NnamdiRaphael A AbongAmuam Andrew BengMathias Eyong EsumBertrand L NdzeshangDesmond Akumtoh NkimbengSamuel TeghenAnicetus SuirengErnerstine Ebot AshuEmmanuel KahMichele E MurdochRachael ThomsonSally TheobaldPeter EnyongJoseph D Turner
Published in: BMJ global health (2021)
CDTI alone is unlikely to achieve elimination in those high transmission areas where low participation is commonly associated with the fear of adverse events, despite the current quasi absence of high-risk levels of loiasis. Such persisting historical memories and fear of ivermectin might impact adherence to CDTI also in areas with historical presence but current absence of loiasis. Because such issues are unlikely to be tackled by CDTI adaptive measures, alternative strategies are needed for onchocerciasis elimination where negative perception of ivermectin is an entrenched barrier to community participation in programmes.
Keyphrases
  • drug administration
  • physical activity
  • healthcare
  • prefrontal cortex
  • emergency department
  • adipose tissue
  • skeletal muscle